Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials-Reference-Cited by-同舟云学术

Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials

Published:2021 Issue:3 Volume:11 Page:1207-1231
ISSN:1838-7640
Container-title:Theranostics
language:en
Short-container-title:Theranostics

Author:

Han Young Joo,Lee Keum Hwa,Yoon Sojung,Nam Seoung Wan,Ryu Seohyun,Seong Dawon,Kim Jae Seok,Lee Jun Young,Yang Jae Won,Lee Jin Hee,Koyanagi Ai,Hong Sung Hwi,Dragioti Elena,Radua Joaquim,Smith Lee,Oh Hans,Ghayda Ramy Abou,Kronbichler Andreas,Effenberger Maria,Kresse Daniela,Denicolò Sara,Kang Woosun,Jacob Louis,Shin Hanwul,Shin Jae Il

Publisher

Ivyspring International Publisher

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Medicine (miscellaneous)

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses;Heliyon;2023-10

2. A comprehensive insight on the challenges for COVID-19 vaccine: A lesson learnt from other viral vaccines;Heliyon;2023-06

3. Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2;European Journal of Medicinal Chemistry;2023-04

4. In vitro and in vivo suppression of SARS‐CoV‐2 replication by a modified, short, cell‐penetrating peptide targeting the C‐terminal domain of the viral spike protein;Journal of Medical Virology;2023-03

5. Severe Acute Respiratory Syndrome Associated Corona Virus [SARS-CoV];Emerging Human Viral Diseases, Volume I;2023